KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.90 $2.68 Friday, 26th Apr 2024 FGEN stock ended at $1.04. This is 1.96% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 8.67% from a day low at $0.98 to a day high of $1.06.
90 days $0.88 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Mar 23, 2023 $18.71 $18.94 $18.20 $18.67 558 662
Mar 22, 2023 $19.30 $19.69 $18.56 $18.60 932 607
Mar 21, 2023 $20.19 $20.20 $19.17 $19.41 702 245
Mar 20, 2023 $20.10 $20.10 $19.72 $20.00 932 051
Mar 17, 2023 $20.46 $20.46 $19.68 $20.00 1 204 873
Mar 16, 2023 $19.84 $20.61 $19.61 $20.21 924 718
Mar 15, 2023 $20.26 $20.26 $19.46 $20.00 890 992
Mar 14, 2023 $20.56 $20.74 $19.99 $20.06 1 065 003
Mar 13, 2023 $19.83 $20.25 $19.83 $20.01 1 102 511
Mar 10, 2023 $20.14 $20.24 $19.67 $20.12 1 610 788
Mar 09, 2023 $21.12 $21.30 $20.00 $20.17 1 080 206
Mar 08, 2023 $21.34 $21.34 $20.71 $21.03 521 004
Mar 07, 2023 $21.50 $22.32 $21.12 $21.34 689 143
Mar 06, 2023 $21.90 $21.90 $21.29 $21.73 859 749
Mar 03, 2023 $22.27 $22.27 $21.71 $22.02 703 941
Mar 02, 2023 $21.87 $22.44 $21.60 $22.23 1 264 494
Mar 01, 2023 $22.32 $22.91 $21.98 $22.04 890 756
Feb 28, 2023 $23.53 $23.53 $21.83 $22.20 2 318 597
Feb 27, 2023 $22.53 $22.71 $22.22 $22.51 606 244
Feb 24, 2023 $22.15 $22.60 $21.80 $22.21 635 014
Feb 23, 2023 $22.62 $22.69 $22.17 $22.44 547 859
Feb 22, 2023 $22.85 $23.00 $22.33 $22.52 629 348
Feb 21, 2023 $23.44 $23.49 $22.57 $22.60 1 128 904
Feb 17, 2023 $23.65 $23.94 $23.16 $23.81 529 537
Feb 16, 2023 $23.92 $24.13 $23.40 $23.58 621 759
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT